| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/27/2001 | CN1300597A Composition for treating cancer by magnetic positioning and its preparing process |
| 06/27/2001 | CN1300596A Dual-nm material for treatint cancer by magnetic positioning and its preparing process |
| 06/27/2001 | CN1300590A Use of coating as taste masking agent for oral preparation |
| 06/27/2001 | CN1300589A Process for preparing dried powder of active lactobacillus |
| 06/27/2001 | CN1300562A Composition containing fat-soluble vitamins |
| 06/27/2001 | CN1067590C Protein granule composition suitable for intravenous injection |
| 06/27/2001 | CN1067589C Protein granules suitable for intravenous injection |
| 06/27/2001 | CN1067585C Mongolian medicine prescription for treating skin disease and preparation method thereof |
| 06/27/2001 | CN1067582C Desensitizing chewing gum containing tea extract and is preparing process |
| 06/27/2001 | CN1067577C Preparation of isotomic shengmei injecta. |
| 06/27/2001 | CN1067572C Sprayed powder for treating macerative erosive beriberi |
| 06/27/2001 | CN1067570C Chinese medicine for AIDS and preparing process therefor |
| 06/27/2001 | CN1067560C Compounded Chinese meldicinal preparation containing ginseng and american ginseng and preparation method thereof |
| 06/27/2001 | CN1067558C Blood-enriching agent and preparation thereof |
| 06/27/2001 | CN1067557C Tablet for promoting hair growth |
| 06/27/2001 | CN1067556C Pills for stimulating |
| 06/27/2001 | CN1067548C Preparation for beta-carotene or carotene micro capsule and application thereof |
| 06/26/2001 | US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract |
| 06/26/2001 | US6252060 Antiviral liponucleosides: treatment of hepatitis B |
| 06/26/2001 | US6251952 Method of using lachrymatory agents for moisturizing the eyes |
| 06/26/2001 | US6251945 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 06/26/2001 | US6251941 Use of inhaled retinoids in the prevention of cancer |
| 06/26/2001 | US6251939 Carbamate-based cationic lipids |
| 06/26/2001 | US6251924 Pharmaceutical composition |
| 06/26/2001 | US6251920 Administering tamoxifen or its structural analogs for prophylaxis and therapy of atherosclerosis, thrombosis, myocardial infarction and stroke |
| 06/26/2001 | US6251879 Reducing wool fiber diameter in wool producing animal by administering effective amount of antimethanogenic agent for time and under conditions sufficient to allow wool growth |
| 06/26/2001 | US6251877 Topically administering to individual composition comprising purified beta-1,6-branched-beta-1,3-glucan from schizophyllum commune in amount effective to cause proliferation of skin cells |
| 06/26/2001 | US6251859 Deepithelialized skin diffusion cell system |
| 06/26/2001 | US6251684 Uniform beads |
| 06/26/2001 | US6251678 Mixture of virus particles, salt, histidine buffer and nonionic surfactant |
| 06/26/2001 | US6251673 Method for manufacturing an implant consisting of a carrier material containing medically active agents |
| 06/26/2001 | US6251663 Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases |
| 06/26/2001 | US6251599 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 06/26/2001 | US6251478 Sensitive substance encapsulation |
| 06/26/2001 | US6251441 Stable, optically clear compositions |
| 06/26/2001 | US6251437 Liquid/powder acid concentrate for dialysate and a method of making the same |
| 06/26/2001 | US6251436 Drug preparations for treating sexual dysfunction |
| 06/26/2001 | US6251435 Hydrogels containing absorbable polyoxaamides |
| 06/26/2001 | US6251434 Preparations of non-steroidal analgesics |
| 06/26/2001 | US6251432 Sustained release dosage form unit having latex coating and method of making the same |
| 06/26/2001 | US6251430 Water insoluble polymer based sustained release formulation |
| 06/26/2001 | US6251429 Programmed release ambroxol—HCl dosage forms |
| 06/26/2001 | US6251428 Preparation of aqueous clear solution dosage forms with bile acids |
| 06/26/2001 | US6251427 Pharmaceutical capsule compositions containing loratadine and psuedoephedrine |
| 06/26/2001 | US6251426 Ibuprofen-containing softgels |
| 06/26/2001 | US6251425 Glucoside paucilamellar vesicles |
| 06/26/2001 | US6251423 Bandages and dressings |
| 06/26/2001 | US6251421 Pharmaceutical composition containing psyllium fiber and a lipase inhibitor |
| 06/26/2001 | US6251418 Delivering and implanting pellets containing a drug into the myocardial tissue; treating restenosis |
| 06/26/2001 | US6251407 And adjuvant selected from manganese gluconate, calcium gluconate, zinc gluconate, calcium fructoheptonate, zinc glucoheptonate, or calcium glycerophosphate and an oily phase ester of ethoxylated fatty acids; immunostimulatory |
| 06/26/2001 | US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution |
| 06/26/2001 | US6251371 Treatment of skin or mucosa inflammation by topical treatment with preparation containing dichlorobenzyl alcohol |
| 06/26/2001 | US6251368 Aerosol drugs salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate and physiologically acceptable salts |
| 06/26/2001 | US6251355 Fine cisplatin powder and process for the production thereof |
| 06/26/2001 | US6250469 Formulations for protection of peg-interferon alpha conjugates |
| 06/26/2001 | US6250300 System for dispensing pharmaceutically active compounds |
| 06/26/2001 | US6250298 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 06/26/2001 | CA2278133C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 06/23/2001 | CA2329574A1 Controlled release composition |
| 06/23/2001 | CA2329556A1 Method of preparing a watersoluble film |
| 06/23/2001 | CA2329453A1 Helium and neon as means for delivering drug in inhaler |
| 06/22/2001 | CA2329296A1 Method for immobilizing allergens |
| 06/21/2001 | WO2001044485A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 06/21/2001 | WO2001044420A2 Glyceride oil based coating waxes |
| 06/21/2001 | WO2001044262A1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 06/21/2001 | WO2001044199A1 Compounds and compositions for delivering active agents |
| 06/21/2001 | WO2001044198A1 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules |
| 06/21/2001 | WO2001044159A1 Organic glasses and precursors therefor |
| 06/21/2001 | WO2001044140A1 Bonded products and methods of fabrication therefor |
| 06/21/2001 | WO2001043943A1 Device and method for producing solid shapes containing an active ingredient |
| 06/21/2001 | WO2001043935A2 Injection molding method for neutral and acidic-group containing (meth)acrylate copolymers |
| 06/21/2001 | WO2001043853A1 Method for capturing fine particles by percolation in a bed of granules |
| 06/21/2001 | WO2001043778A1 Use of cationic lipids for intracellular protein delivery |
| 06/21/2001 | WO2001043776A1 Pharmaceutical formulation for intravenous or intramuscular octreotide administration |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043771A1 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory iga's |
| 06/21/2001 | WO2001043766A1 Colistin sulfate granules |
| 06/21/2001 | WO2001043765A2 Method for localized administration of fibrinolytic metalloproteinases |
| 06/21/2001 | WO2001043762A2 Polypeptide compositions with improved stability |
| 06/21/2001 | WO2001043749A2 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 06/21/2001 | WO2001043748A2 Implant composition containing melengestrol acetate and trenbolone acetate |
| 06/21/2001 | WO2001043747A1 Matrix tablet for prolonged release of trimetazidine after oral administration |
| 06/21/2001 | WO2001043743A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | WO2001043742A1 Novel processes for making- and a new crystalline form of- leflunomide |
| 06/21/2001 | WO2001043736A1 Drugs for relieving hemicrania |
| 06/21/2001 | WO2001043735A1 Nitroglycerin ointment for treatment of pain associated with anal disease |
| 06/21/2001 | WO2001043734A2 Transdermal administration of phenylpropanolamine |
| 06/21/2001 | WO2001043733A2 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| 06/21/2001 | WO2001043729A1 Adhesive preparations |
| 06/21/2001 | WO2001043728A1 Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy |
| 06/21/2001 | WO2001043727A1 Electrostatic application of powder material to solid dosage forms |
| 06/21/2001 | WO2001043726A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | WO2001043725A1 Controlled release kci tablet formulations |
| 06/21/2001 | WO2001043724A1 Microcapsules for sustained release of drugs |
| 06/21/2001 | WO2001043722A2 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 06/21/2001 | WO2001043721A2 Dosage forms having a barrier layer to laser ablation |
| 06/21/2001 | WO2001043720A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | WO2001043704A1 A skin care composition that mediates cell to cell communication |
| 06/21/2001 | WO2001043702A1 Stabilizers for l-ascorbic acid-2-sodium phosphate |
| 06/21/2001 | WO2001043698A1 Topical ointment |